skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Radioimmunoassay of buprenorphine in urine: Studies in patients and in a drug clinic

Journal Article · · Journal of Analytical Toxicology; (USA)
DOI:https://doi.org/10.1093/jat/13.2.100· OSTI ID:6999186
; ; ;  [1]; ;  [2];  [3]
  1. DPC European Research Institute, Witney (England)
  2. Jervis Street Hospital, Dublin (Ireland)
  3. Abingdon Hospital, Oxford (England)

A radioimmunoassay kit (DPC buprenorphine double antibody) was evaluated with clinical samples and samples from a drug clinic. Urine samples were collected over a 2-day period from 5 hospital in-patients receiving sublingual buprenorphine, 400 to 2000 {mu}g/day, for the relief of chronic pain. Samples were measured before and after enzymatic hydrolysis. Urine buprenorphine concentrations were measurable at all doses studied (minimum value 5.6 ng/mL) and were greater with larger doses. The increase in concentration after hydrolysis averaged 49% and was similar for all doses studied. The authors conclude that the method has extensive cross-reactivity with glucuronides of buprenorphine and its metabolites and that samples may be analyzed without prior hydrolysis. The prevalence of buprenorphine use in 97 patients attending a drug clinic was also studied. Sixty (62%) had measurable urinary buprenorphine concentrations of 1 ng/mL or more by direct assay. The buprenorphine users were significantly younger and reported significantly greater use of opiates than nonusers.

OSTI ID:
6999186
Journal Information:
Journal of Analytical Toxicology; (USA), Vol. 13:2; ISSN 0146-4760
Country of Publication:
United States
Language:
English